Ultragenyx Pharmaceutical Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€34.60
Target price
04.08.24
€86.28
Performance (%)
15.03%
Price
03.05.24
€39.80
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley currently has a performance of 15.03%. This prediction currently runs until 04.08.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -3.865% | -3.865% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Morgan_Stanley for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $95.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.60
03.11.23
03.11.23
€78.49
03.11.24
03.11.24
9.29%
03.05.24
03.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
10.10.23
10.10.23
€84.74
10.10.24
10.10.24
16.86%
03.05.24
03.05.24